Nusch Arnd - Praxis | 人才画像

基本信息

浏览量：76

职业迁徙

个人简介

暂无内容

研究兴趣

论文共 144 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

On-treatment (tx) Dynamic Circulating Tumor DNA Changes (δctdna) Associated with Progression-Free Survival (PFS) and Overall Survival (OS) of Patients (pts) with HR+/HER22 Advanced Breast Cancer (ABC) in MONALEESA-3 (ML-3)

Stephen K. L. Chia,Nadia Solovieff, Mukta Joshi, Seock-Ah Im, Giulia Valeria Bianchi, Luis de la Cruz-Merino, Guy Heinrich Maria Jerusalem, Gabe S. Sonke,Arnd Nusch,J. Thaddeus Beck,Dennis J. Slamon, Craig Wang,Juan Pablo Zarate,Fei Su,Patrick Neven

JOURNAL OF CLINICAL ONCOLOGYno. 16 (2024)

引用0浏览0引用

Comparison of TKI and CPI Strategies As First-Line Treatment of Patients with Advanced Renal Cell Carcinoma: Real-world Outcome Data from the German Research Platform CARAT

Peter J. Goebell,Martin Boegemann,Arnd Nusch,Viktor Gruenwald,Lothar Mueller,Eyck von der Heyde,Dietmar Reichert,Uwe Marc Martens, Carolin Lennartz,Michaela Koska,Martina Jaenicke,Karin Potthoff,Norbert Marschner,Carsten Gruellich,Michael D. Staehler

JOURNAL OF CLINICAL ONCOLOGYno. 16 (2024)

引用0浏览0引用

On-treatment (tx) Dynamic Circulating Tumor DNA Changes (∆ctdna) Associated with Progression-Free Survival (PFS) and Overall Survival (OS) of Patients (pts) with HR+/HER2− Advanced Breast Cancer (ABC) in MONALEESA-3 (ML-3)

Stephen K. L. Chia,Nadia Solovieff,Mukta Joshi,Seock-Ah Im,Giulia Valeria Bianchi,Luis de la Cruz-Merino,Guy Heinrich Maria Jerusalem,Gabe S. Sonke,Arnd Nusch,J. Thaddeus Beck,Dennis J. Slamon,Craig Wang,Juan Pablo Zarate,Fei Su,Patrick Neven

Journal of Clinical Oncologyno. 16_suppl (2024): 1012-1012

引用0浏览0引用

Disease-free Survival As a Surrogate for Overall Survival in HR+/HER2-early Breast Cancer: A Correlation Analysis

Michael Untch,David Perol,Erica L. Mayer,Javier Cortes,Arnd Nusch,David Cameron,Carlos Barrios,Thomas Delea, Andrii Danyliv,Namita Mishra,Rhea Gupta,Purnima Pathak,Peter A. Fasching

European Journal of Cancer (2024): 113977-113977

引用0浏览0WOS引用

Abstract PO1-04-12: Palbociclib Versus Ribociclib in First-Line Treatment of Patients with Hormone-Receptor Positive HER2 Negative Advanced Breast Cancer – Real World Outcome Data from the German Registry Platform OPAL

Marc Thill,Mark-Oliver Zahn,Anja Welt,Arnd Nusch,Matthias Zaiss, Kathrin Engelken,Gabriele Kaltenecker, Kai Ringwald, Katja Gratzke,Lisa Kruggel,Martina Jänicke,Holger Schulz,Christoph Losem,Volker Hagen, Roland Fricker,Elmar Stickeler,Nadia Harbeck,Achim Wöckel,Thomas Decker

Cancer Researchno. 9_Supplement (2024): PO1-04

引用0浏览0引用

Treatment and Outcome in Metastatic Lobular Breast Cancer in the Prospective German Research Platform OPAL

M. Thill,M.-O. Zahn,A. Welt,E. Stickeler,A. Nusch,T. Fietz,J. Rauh,N. Wetzel,L. Kruggel,M. Jänicke,N. Marschner,N. Harbeck,A. Wöckel,T. Decker

Breast cancer research and treatmentno. 3 (2023): 545-553

引用1浏览0WOS引用

1L maintenance therapy in patients with newly diagnosed advanced or metastatic ovarian cancer in routine care in Germany: results from the German registry platform SMARAGD

I. Juhasz-Boess,A. Nusch,M. Zaiss, R. Fuchs, A. Mueller,M. Jaenicke, S. Winter,C. Lennartz, O. Vahtrik,N. Marschner,E. Stickeler,A. Welt,D. Watermann,A. Woeckel,T. Decker,K. Gratzke

ONCOLOGY RESEARCH AND TREATMENT (2023): 152-153

引用0浏览0引用

Treatment of elderly patients (pts; > 75 years) with 1st-line ribociclib (RIB) plus endocrine therapy (ET) or endocrine monotherapy in clinical routine: Real-world data from the RIBANNA study (5th interim analysis (IA))

T. Decker,C. Brucker,P. Fasching,T. Goehler, C. Jackisch, J. Janssen,A. Koehler,K. Luedtke-Heckenkamp, D. Luetner,M. Van Mackelenbergh,F. Marme,A. Nusch,B. Rautenberg,T. Reimer, M. Schmidt,R. Weide,P. Wimberger,S. Maslanka Figueroa,C. Roos,A. Woeckel

ANNALS OF ONCOLOGY (2023): S354-S355

引用0浏览0引用

加载更多

作者统计

合作学者

合作机构

D-Core

合作者
学生
导师

暂无相似学者，你可以通过学者研究领域进行搜索筛选

数据免责声明

页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn